Skip to main content

Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)

CBE ID
0070e
Project
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description

Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF <40% who were prescribed beta-blocker therapy

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Numerator

    Patients who were prescribed beta-blocker therapy

    Denominator

    All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior (within the past 3 years) MI or a current or prior LVEF <40%

    Exclusions

    Denominator Exceptions:
    Documentation of medical reason(s) for not prescribing beta-blocker therapy (e.g., allergy, intolerance, other medical reasons).

    Documentation of patient reason(s) for not prescribing beta-blocker therapy (e.g., patient declined, other patient reasons).

    Documentation of system reason(s) for not prescribing beta-blocker therapy (e.g., other reasons attributable to the health care system).

  • Most Recent Endorsement Activity
    Endorsed Cardiovascular Spring Cycle 2019
    Initial Endorsement
    Next Planned Maintenance Review
    Cardiovascular Spring 2025
    Endorsement Status
    Last Updated
  • Steward Organization Email
    Steward Organization Copyright

    Copyright 2019 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.